Genetic Diagnosis of alpha 1 antitrypsin deficiency.
The A1AT Genotyping Test is a last generation genetic test that analyzes simultaneously the most prevalent mutations in the world associated with the disease in DNA extracted from a blood (whole and DBS) or saliva sample.
The presentation of the product allows the analysis of up to 192 samples per kit.
The deficit of alpha-1 is a genetic inherited disorder that can cause the
development of the disease chronic obstructive pulmonary disease (COPD), mainly emphysema, and various
types of liver diseases. It is characterized by very low levels, or nonexistent, of the alpha-1 antitrypsin protein in
blood. The main function of this protein is to protect the lung tissue from inflammation caused by
infections and irritants inhaled, such as tobacco smoke.
This test is FDA approved and designed for use in Luminex
100/200 equipment.
With the collaboration of:
